EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 208 filers reported holding EXELIXIS INC in Q3 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,211,000 | -24.4% | 50,000 | -23.1% | 0.35% | -38.0% |
| Q2 2017 | $1,601,000 | -1.5% | 65,000 | -13.3% | 0.56% | -29.4% |
| Q1 2017 | $1,625,000 | +36.2% | 75,000 | -6.2% | 0.80% | +12.0% |
| Q4 2016 | $1,193,000 | +69.5% | 80,000 | +45.5% | 0.71% | +146.5% |
| Q3 2016 | $704,000 | – | 55,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |